BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6530547)

  • 1. Intracellular electrolytes during antihypertensive treatment with a loop diuretic.
    Zidek W; Losse H; Schmidt W; Fehske KJ; Vetter H
    J Hypertens; 1984 Aug; 2(4):393-5. PubMed ID: 6530547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular calcium in essential hypertension. A parameter for assessing effective antihypertensive treatment.
    Zidek W; Baumgart P; Karoff C; Losse H; Vetter H
    J Hypertens Suppl; 1984 Dec; 2(3):S495-7. PubMed ID: 6599706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular sodium and calcium during antihypertensive treatment.
    Zidek W; Karoff C; Baumgart P; Losse H; Fehske KJ; Häcker W; Vetter H
    Klin Wochenschr; 1985; 63 Suppl 3():147-9. PubMed ID: 2860268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment.
    Beuckelmann D; Erdmann E
    Klin Wochenschr; 1986 Oct; 64(21):1101-5. PubMed ID: 3807255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension].
    Saitta A; Saitta MN; Bonaiuto M; Castaldo M; Sardo A; Messina A; Cinquegrani M; Squadrito G; Campo GM; Squadrito F
    Clin Ter; 1997; 148(5-6):237-47. PubMed ID: 9377859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of trichlormethiazide and amiloride on cellular Na+, K+ and Mg+ concentrations].
    Kisters K; Zidek W; Rahn KH
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1837-9. PubMed ID: 2609140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man.
    Young MA; Watson RD; Littler WA
    J Hypertens; 1985 Oct; 3(5):481-3. PubMed ID: 4067304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intracellular sodium and calcium in essential hypertension during diuretic treatment.
    Spieker C; Zidek W; Häcker W; Schmidt W; Vetter H
    Arzneimittelforschung; 1988 Jan; 38(1A):188-90. PubMed ID: 3370065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraerythrocytic potassium and diuretic therapy].
    Otto GL; de Carvalho JG; Laffitte A; Baroni G
    Arq Bras Cardiol; 1989 Feb; 52(2):91-3. PubMed ID: 2596994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables.
    Leary WP; Reyes AJ
    S Afr Med J; 1981 Dec; 60(24):925-8. PubMed ID: 7302776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive effect of indapamide and its effect on extracellular and intracellular Na and K concentrations in red blood cells].
    Du FH; Wang Q
    Zhonghua Nei Ke Za Zhi; 1985 Dec; 24(12):705-8, 767. PubMed ID: 3830615
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disturbed sodium and calcium exchange in erythrocytes of spontaneously hypertensive rats (author's transl)].
    Zidek W; Vetter H; Zumkley H; Losse H
    Z Kardiol; 1981 Jun; 70(6):462-5. PubMed ID: 6266172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential hypertension versus secondary hypertension: discrimination by intracellular electrolytes.
    Spieker C; Zidek W; Lange-Asschenfeldt H; Losse H; Vetter H
    Klin Wochenschr; 1985; 63 Suppl 3():20-2. PubMed ID: 3999636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell K+ could be a marker of K+ changes in other cells involved in blood pressure regulation.
    Delgado MC; Delgado-Almeida A
    J Hum Hypertens; 2003 May; 17(5):313-8. PubMed ID: 12756403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte contents of electrolytes (Na, K, Mg, Zn) in healthy male controls and offspring to established hypertensive patients: a follow-up study.
    Nelson D; Henningsen NC
    Scand J Clin Lab Invest; 1983 Jun; 43(4):317-22. PubMed ID: 6635537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of piretanide on potassium balance in hypertension.
    Meyer BH; Müller FO; Werkman IM; Luus HG; Lötter MG; Grigoleit HG
    S Afr Med J; 1985 Feb; 67(6):206-8. PubMed ID: 3983764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ; Machnik H; Studt J; Fink R
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the antihypertensive effect of the new saluretic drug, piretanide].
    Radaelli L; Cosci P; Grillo C; Bertoli S; Minetti L
    Clin Ter; 1982 Jul; 102(1):33-9. PubMed ID: 7140169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.